8 billion people. 1 data suite.

IHME is the world's largest independent health data resource with state-of-the-art search, analytic, and display tools.


​The Institute for Health Metrics and Evaluation's (IHME) mission is to provide comprehensive data and analytics to support efforts to improve health worldwide. ​

IHME's databases are the result of a $500m investment, growing at $50m per year into the collection, validation and analysis of worldwide disease data.

IHME's comprehensive data suite is a result of work from:
  • 500+ full-time professionals 
  • 30 full-time university faculty
  • 30-member scientific counsel
  • 10,000+ international collaborators 

IHME Client Services provides data and analytic guidance to heads of state, major philanthropists, fortune 500 companies in the pharma, insurance and health care and many other industries. 
Picture
IHME’s team of 500 professionals work from its Seattle base, the new Hans Rosling Center for Population Health at the University of Washington.
Picture
IHME’s core funding is provided by the Bill & Melinda Gates Foundation, and its leadership by Dr. Christopher Murray, holder of the Gairdner Global Health Award.

IHME equips decision makers with data-driven insights that drive confident, strategic decision making.

IHME's data cover 204 countries and 900+ subnational units.

Picture
IHME data are compiled from 200,000+ sources and updated annually.
Color variations show all cause deaths rates (per 100,000) in 2019.
Picture
Kyoto, Japan: both sexes, all ages, 2019, DALYs
Picture
Pennsylvania, USA: both sexes, all ages, 2019, DALYs
The Treemap chart is essentially a square pie chart; the size of the box is proportionate to the disease burden. Blue = non-communicable diseases, Red = communicable, maternal, neonatal, and nutritional diseases, Green = Injuries.
Comprehensive, comparable estimates help facilitate: 
  • Investments in health and impact measurement, 
  • Cross-functional knowledge sharing,  
  • Clinical trial site selection and design,
  • Disease and modifiable risk factor forecasting,  
  • Quantifying disease prevalence and burden across markets.​​
​IHME leads the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), the single largest scientific effort to measure trends and levels in population health. The GBD study is the gold standard in population health metrics. ​
The GBD project produces time series data since 1990 for:
  • Incidence of disease and injury for 369 causes
  • Prevalence of disease and injury for 369 causes
  • Prevalence and incidence for disease/injury sequelae
  • Death by cause for 282 causes
  • All cause mortality
  • Years of life lost due to premature death (YLLs) for 249 causes
  • Years lived with disability (YLDs) for 369 causes
  • Disability adjusted life years (DALYs) for 369 causes
  • Life expectancy and healthy life expectancy (HALE)
  • Risk factor attribution for deaths, YLLs, YLDs, and DALYs
  • Exposure to 87 risk factors
  • Relative risks of mortality for each risk-outcome pair.
The GBD quantifies health loss due to all diseases, injuries, and risk factors, for each country and many subnational areas, by age and sex, and over time. 

​GBD geographical units are mutually exclusive and globally exhaustive, broken down by:
  • 900+ total geographies within 204 countries and territories, 21 regions and 7 super-regions.
  • Annual trends from 1990 
  • Forecasts through 2050
  • 38 age groups, from birth to 95+
  • Severity, signs, and symptoms related to health conditions
  • Mapped to ICD-9 and ICD-10 codes
Learn more about available IHME Data and services ​here. ​

IHME Client Services  |  Institute for Health Metrics and Evaluation at the University of Washington, Seattle, WA USA  |  [email protected]